The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature
Open accessAbstract
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial pneumonia of unknown aetiology. It is a rare disease, and its incidence and prevalence are not clear. Therefore, we sought to review the published evidence on the global epidemiology of IPF. A comprehensive review of English language literature was performed by searching Medline and EMBASE for studies on IPF epidemiology published between January 1990 and August 2011. Studies providing quantitative data on IPF incidence and/or prevalence were identified and key data collected. 15 studies reporting on the incidence and/or prevalence of IPF were identified and summarised. IPF prevalence estimates in the USA varied between 14 and 27.9 cases per 100,000 population using narrow case definitions, and 42.7 and 63 per 100,000 population using broad case definitions. In Europe, IPF prevalence ranged from 1.25 to 23.4 cases per 100,000 population. The annual incidence of IPF in the USA was estimated at 6.8–8.8 per 100,000 population using narrow case definitions and 16.3–17.4 per 100,000 population using broad case definitions. In Europe, the annual incidence ranged between 0.22 and 7.4 per 100,000 population. IPF prevalence and incidence increase with age, are higher among males and appear to be on the increase in recent years. IPF is an orphan disease that affects a potentially increasing number of people in Europe and the USA. The observed variability in IPF incidence and prevalence may be explained by the differences in diagnostic criteria used, case definition, study population and study design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
King, T. E., Pardo, A., & Selman, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60052-4 · Cited by 2,194
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
Raghu, G., Weycker, D., Edelsberg, J., Bradford, W. Z., & Oster, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-163oc · Cited by 1,310
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
BJORAKER, J. A., RYU, J. H., EDWIN, M. K., MYERS, J. L., TAZELAAR, H. D., SCHROEDER, D. R., & OFFORD, K. P. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.1.9704130 · Cited by 1,039
The epidemiology of interstitial lung diseases.
Coultas, D. B., Zumwalt, R. E., Black, W. C., & Sobonya, R. E. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.4.7921471 · Cited by 946
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Lettieri, C. J., Nathan, S. D., Barnett, S. D., Ahmad, S., & Shorr, A. F. (2006) · Chest · doi:10.1378/chest.129.3.746 · Cited by 879
international consensus statement
Clements, R. V., & Simanowitz, A. (2000) · Cited by 852
Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK
Gribbin, J., Hubbard, R. B., Le Jeune, I., Smith, C. J. P., West, J., & Tata, L. J. (2006) · Thorax · doi:10.1136/thx.2006.062836 · Cited by 576
Incidence, Prevalence, and Clinical Course of Idiopathic Pulmonary Fibrosis
Fernández Pérez, E. R., Daniels, C. E., St. Sauver, J., Hartman, T. E., Bartholmai, B. J., Yi, E. S., Ryu, J. H., & Schroeder, D. R. (2010) · Chest · doi:10.1378/chest.09-1002 · Cited by 509
Cryptogenic fibrosing alveolitis: clinical features and their influence on survival
Turner-Warwick, M., Burrows, B., & Johnson, A. (1980) · Thorax · doi:10.1136/thx.35.3.171 · Cited by 508
The rising incidence of idiopathic pulmonary fibrosis in the UK
Navaratnam, V., Fleming, K. M., West, J., Smith, C. J. P., Jenkins, R. G., Fogarty, A., & Hubbard, R. B. (2011) · Thorax · doi:10.1136/thx.2010.148031 · Cited by 484
Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
Cottin, V., Le Pavec, J., Prévot, G., Mal, H., Humbert, M., Simonneau, G., Cordier, J.-F., & GERM“O”P (2010) · European Respiratory Journal · doi:10.1183/09031936.00038709 · Cited by 478
Clinical and Pathologic Features of Familial Interstitial Pneumonia
Steele, M. P., Speer, M. C., Loyd, J. E., Brown, K. K., Herron, A., Slifer, S. H., Burch, L. H., Wahidi, M. M., Phillips, J. A., Sporn, T. A., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200408-1104oc · Cited by 432
Classification and Natural History of the Idiopathic Interstitial Pneumonias
Kim, D. S., Collard, H. R., & King, T. E. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200601-005tk · Cited by 431
Meltzer, E. B., & Noble, P. W. (2008) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-3-8 · Cited by 407
Baumgartner, K. B., Samet, J. M., Coultas, D. B., Stidley, C. A., Hunt, W. C., Colby, T. V., Waldron, J. A., & Centers, C. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.4.307 · Cited by 374
Delayed Access and Survival in Idiopathic Pulmonary Fibrosis: A Cohort Study
Lamas, D. J., Kawut, S. M., Bagiella, E., Philip, N., Arcasoy, S. M., & Lederer, D. J. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0668oc · Cited by 314
Hodgson, U. (2002) · Thorax · doi:10.1136/thorax.57.4.338 · Cited by 249
Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival
Turner-Warwick, M., Burrows, B., & Johnson, A. (1980) · Thorax · doi:10.1136/thx.35.8.593 · Cited by 244
Comparison of registries of interstitial lung diseases in three European countries
Thomeer, M. J., Costabel, U., Rizzato, G., Poletti, V., & Demedts, M. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.18s320114 · Cited by 216
Epidemiology of interstitial lung diseases in Greece
Karakatsani, A., Papakosta, D., Rapti, A., Antoniou, K. M., Dimadi, M., Markopoulou, A., Latsi, P., Polychronopoulos, V., Birba, G., Ch, L., et al. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.03.001 · Cited by 208
Early Interstitial Lung Disease in Familial Pulmonary Fibrosis
Rosas, I. O., Ren, P., Avila, N. A., Chow, C. K., Franks, T. J., Travis, W. D., McCoy, J. P., May, R. M., Wu, H.-P., Nguyen, D. M., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200702-254oc · Cited by 180
Familial Idiopathic Pulmonary Fibrosis
Lee, H.-L., Ryu, J. H., Wittmer, M. H., Hartman, T. E., Lymp, J. F., Tazelaar, H. D., & Limper, A. H. (2005) · Chest · doi:10.1378/chest.127.6.2034 · Cited by 169
REGISTRATION OF INTERSTITIAL LUNG DISEASES BY 20 CENTRES OF RESPIRATORY MEDICINE IN FLANDERS
Thomeer, M., DEMEDTS, M. G., Vandeurzen, K., & VRGT Working group on Interstitial Lung Diseases (2001) · Acta Clinica Belgica · doi:10.1179/acb.2001.026 · Cited by 168
Egan, J. J., Stewart, J. P., Hasleton, P. S., Arrand, J. R., Carroll, K. B., & Woodcock, A. A. (1995) · Thorax · doi:10.1136/thx.50.12.1234 · Cited by 166
Occupational and Environmental Factors and Idiopathic Pulmonary Fibrosis in Japan
Miyake, Y., Sasaki, S., Yokoyama, T., Chida, K., Azuma, A., Suda, T., Kudoh, S., Sakamoto, N., Okamoto, K., Kobashi, G., et al. (2005) · The Annals of Occupational Hygiene · doi:10.1093/annhyg/meh090 · Cited by 120
Racial and Ethnic Disparities in Idiopathic Pulmonary Fibrosis: A UNOS/OPTN Database Analysis
Lederer, D. J., Arcasoy, S. M., Barr, R. G., Wilt, J. S., Bagiella, E., D’Ovidio, F., Sonett, J. R., & Kawut, S. M. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01480.x · Cited by 69
Incidence and prevalence of cryptogenic fibrosing alveolitis in a Norwegian community
von Plessen, C., Grinde, Ø., & Gulsvik, A. (2003) · Respiratory Medicine · doi:10.1053/rmed.2002.1466 · Cited by 53
Ohno, S., Nakaya, T., Bando, M., & Sugiyama, Y. (2008) · Respirology · doi:10.1111/j.1440-1843.2008.01349.x · Cited by 52
Epidemiology of cryptogenic fibrosing alveolitis in Moravia and Silesia.
Kolek (1994) · PubMed · Cited by 24
Cited by
Senescence and aging: Causes, consequences, and therapeutic avenues
McHugh, D., & Gil, J. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201708092 · Cited by 1,233
“Consequently, age is a risk factor for many diseases (Niccoli and Partridge, 2012), such as cardiovascular disease (North and Sinclair, 2012), dementia (Querfurth and LaFerla, 2010), osteoporosis (Raisz, 1988), osteoarthritis (Raisz, 1988), cancer (de Magalhães, 2013), type 2 diabetes (Gunasekaran and Gannon, 2011), i…”
BackgroundPulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
George, P. M., Wells, A. U., & Jenkins, R. G. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30225-3 · Cited by 1,085
A global view of pulmonary hypertension
Hoeper, M. M., Humbert, M., Souza, R., Idrees, M., Kawut, S. M., Sliwa-Hahnle, K., Jing, Z.-C., & Gibbs, J. S. R. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00543-3 · Cited by 1,039
Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
Wollin, L., Wex, E., Pautsch, A., Schnapp, G., Hostettler, K. E., Stowasser, S., & Kolb, M. (2015) · European Respiratory Journal · doi:10.1183/09031936.00174914 · Cited by 1,005
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
Hutchinson, J., Fogarty, A., Hubbard, R., & McKeever, T. (2015) · European Respiratory Journal · doi:10.1183/09031936.00185114 · Cited by 913
Metadata
- Authors
- Nalysnyk, L., Cid-Ruzafa, J., Rotella, P., & Esser, D.
- Venue
- European Respiratory Review
- Publisher
- European Respiratory Society (ERS)
- Published
- 2012-11-30
- Volume
- 21
- Issue
- 126
- Pages
- 355-361
- ISSN
- 0905-9180 (ISSN-L)
- 1600-0617
- OpenAlex
- W2143924572
- Cited by
- 552
- References
- 32
- FWCI
- 24.19
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.